 | Nov 1, 2007
By:Gary Schwebach, Stephanie Cohen, Matthew Herman
Has the pharmaceutical and biotech industry overextended its signature sales model? Is the selling field now overgrazed and producing less bounty for all? Could the inaccessible-physician problem be customers' way of telling the pharmaceutical industry that the current state of personal promotion is not meeting their needs as well as in the past? Data from RepReview 2007, a study of pharma and biotech sales reps, conducted by G & S Research in partnership with Pharmaceutical Representative magazine, indicates ... maybe.
 |
